ARLINGTON, Va. & REYKJAVIK, Iceland–(BUSINESS WIRE)–Kerecis, the corporate pioneering using fish pores and skin and fatty acids for tissue regeneration and safety, at the moment introduced that the corporate might be attending the Biotech Showcase™ 2023 and the 41st Annual J.P. Morgan Healthcare Conference, which can happen in San Francisco the week of January 9, 2023.
Kerecis founder and CEO Fertram Sigurjonsson and CFO Mike Cadigan will present an outline of Kerecis’ enterprise and up to date company achievements, together with monetary outcomes, monetary projections and updates on progress in gross sales operations. The presentation will happen on the Biotech Showcase on Wednesday, January 11, at 10:45 a.m. within the Hilton San Francisco Union Sq. (333 O’Farrell Avenue, Yosemite C assembly room). The 2 Kerecis executives will even participate in one-on-one conferences on the J.P. Morgan assembly. To e-book a gathering, events ought to contact jpmhc@kerecis.com or name 703-287-8752.
About Kerecis
Kerecis develops merchandise from fish pores and skin and fatty acids for mobile remedy, tissue regeneration and safety. When grafted or implanted on broken human tissue, the patented materials recruits the physique’s personal cells and finally is transformed into dwelling tissue. As a result of no disease-transfer threat exists between cold-water fish and people, the Kerecis fish pores and skin is barely gently processed with the corporate’s EnviroIntact™ methodology and retains its similarity to human tissue. The mild processing with the EnviroIntact methodology preserves the pores and skin’s unique three-dimensional construction, sustaining its inherent pure power, complexity and molecules (corresponding to fatty acids). Medical research have discovered that the Kerecis merchandise heal wounds quicker than competing merchandise.
Kerecis is the one accepted producer of medical units containing intact fish pores and skin on this planet. It’s the fastest-growing and one of many high 5 corporations within the U.S. biologics-skin and dermal-substitute market, in line with SmartTRAK Enterprise Intelligence. Kerecis’ increasing product portfolio contains MariGen®, which is bought to non-public workplaces and wound facilities to deal with diabetic and different continual wounds; GraftGuide®, which is primarily utilized in burn facilities; and SurgiBind® and SurgiClose®, that are used for reconstructive surgical procedure in working rooms. Kerecis is dedicated to the United Nations Sustainable Improvement Objectives. The fish pores and skin utilized in Kerecis merchandise derives from wild and sustainable fish inventory caught in pristine Icelandic waters and processed with 100% renewable power within the city of Isafjordur, near the Arctic Circle. For extra data, go to https://www.kerecis.com.
MariGen, GraftGuide, SurgiBind and SurgiClose are registered emblems and EnviroIntact is a trademark of Kerecis. All different emblems and registered emblems are properties of their respective homeowners.
